- Home
- ADVM vs MVST Comparison
ADVM vs MVST Comparison
Compare ADVM & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- MVST
- Stock Information
- Founded
- ADVM 2006
- MVST 2006
- Country
- ADVM United States
- MVST United States
- Employees
- ADVM N/A
- MVST N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- MVST Industrial Machinery/Components
- Sector
- ADVM Health Care
- MVST Miscellaneous
- Exchange
- ADVM Nasdaq
- MVST Nasdaq
- Market Cap
- ADVM 47.4M
- MVST 1.3B
- IPO Year
- ADVM 2014
- MVST N/A
- Fundamental
- Price
- ADVM $2.35
- MVST $3.61
- Analyst Decision
- ADVM Strong Buy
- MVST Strong Buy
- Analyst Count
- ADVM 5
- MVST 1
- Target Price
- ADVM $23.80
- MVST $3.00
- AVG Volume (30 Days)
- ADVM 346.6K
- MVST 9.1M
- Earning Date
- ADVM 08-11-2025
- MVST 08-07-2025
- Dividend Yield
- ADVM N/A
- MVST N/A
- EPS Growth
- ADVM N/A
- MVST N/A
- EPS
- ADVM N/A
- MVST N/A
- Revenue
- ADVM $1,000,000.00
- MVST $414,941,000.00
- Revenue This Year
- ADVM N/A
- MVST $26.08
- Revenue Next Year
- ADVM $18.82
- MVST $29.71
- P/E Ratio
- ADVM N/A
- MVST N/A
- Revenue Growth
- ADVM N/A
- MVST 21.68
- 52 Week Low
- ADVM $1.78
- MVST $0.15
- 52 Week High
- ADVM $10.14
- MVST $4.72
- Technical
- Relative Strength Index (RSI)
- ADVM 41.22
- MVST 46.96
- Support Level
- ADVM $2.14
- MVST $3.51
- Resistance Level
- ADVM $2.60
- MVST $4.27
- Average True Range (ATR)
- ADVM 0.22
- MVST 0.33
- MACD
- ADVM -0.01
- MVST -0.11
- Stochastic Oscillator
- ADVM 12.39
- MVST 7.97
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.